← All trials
NCT05602961
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2023
- Primary completion
- Aug 31, 2024
- Completion date
- Sep 30, 2024
- First posted
- Nov 2, 2022
- Last posted
- Nov 2, 2022
- Enrollment
- 48
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- GreenLight Biosciences, Inc.Lead sponsor
- Center for Family Health Research (CFHR)Overall official - principal investigator
- Center for Family Health Research (CFHR)Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.